Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project
- PMID: 28474253
- PMCID: PMC5418170
- DOI: 10.1186/s10194-017-0759-5
Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project
Abstract
Background: The Eurolight project assessed the impact of headache disorders in ten EU countries, using the same structured questionnaire but varying sampling methods. In Lithuania, sample selection employed methods in line with consensus recommendations for population-based burden-of-headache studies.
Methods: The survey was cross-sectional. We identified, from the Residents' Register Service, a sample of inhabitants of Kaunas city and surrounding Kaunas region reflecting age (in the range 18-65 years), gender and rural/urban distributions of Lithuania. Medical students called unannounced at their homes and conducted face-to-face interviews employing a structured questionnaire.
Results: Of 1137 people in the pre-identified sample, 573 (male 237 [41.4%], female 336 [58.6%]; mean age 40.9 ± 13.8 years) completed interviews (participation proportion: 50.4%). Gender-adjusted 1-year prevalences were: any headache 74.7%; migraine 18.8%; tension-type headache (TTH) 42.2%; all headache on ≥15 days/month 8.6%; probable medication-overuse headache (pMOH) 3.2%. Migraine (OR: 3.6) and pMOH (OR: 2.9) were associated with female gender. All headache types except TTH were associated with significantly diminished quality of life. Migraine caused a mean 4.5% loss in paid worktime per affected male and 3.5% per affected female. Lost per-person times due to TTH were much less, but to pMOH and other headache on ≥15 days/month much higher. Among the entire workforce, lost productivity to migraine was estimated at 0.7%, to TTH 0.3% and to pMOH or other headache on ≥15 days/month 0.5%. The total of 1.5% may translate directly into lost GDP. Alternative calculations based on headache yesterday (with little recall error) produced, for all headache, a corroborating 1.7%. Similar losses from household work would also drain the nation's economy. Our findings were comparable to those from earlier studies using similar methods in Russia and Georgia.
Conclusions: The multiple burdens from headache in Lithuania indicate substantial ill-health and unmet need for health care. The heavy burdens on individuals are matched by heavy economic burden. Of particular concern is the high prevalence of headache on ≥15 days/month, seen also in Russia and Georgia. Health policy in Lithuania must heed WHO's advice that effective treatment of headache, clearly desirable for its health benefits, is also expected to be cost-saving.
Keywords: Burden; Disability; Global campaign against headache; Health policy; Lithuania; Lost productivity; Medication-overuse headache; Migraine; Population-based study; Public health; Tension-type headache.
Similar articles
-
The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey.J Headache Pain. 2017 Dec;18(1):58. doi: 10.1186/s10194-017-0765-7. Epub 2017 May 25. J Headache Pain. 2017. PMID: 28547735 Free PMC article.
-
The burden of headache disorders in Nepal: estimates from a population-based survey.J Headache Pain. 2015;17:3. doi: 10.1186/s10194-016-0594-0. Epub 2016 Jan 25. J Headache Pain. 2015. PMID: 26810487 Free PMC article.
-
The burdens attributable to headache disorders in Cameroon: national estimates from a population-based door-to-door survey, including a headache-care needs assessment.J Headache Pain. 2024 Aug 16;25(1):133. doi: 10.1186/s10194-024-01831-1. J Headache Pain. 2024. PMID: 39152396 Free PMC article.
-
Prevalence of headache in Europe: a review for the Eurolight project.J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16. J Headache Pain. 2010. PMID: 20473702 Free PMC article. Review.
-
The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache.J Headache Pain. 2014 Jan 27;15(1):5. doi: 10.1186/1129-2377-15-5. J Headache Pain. 2014. PMID: 24467862 Free PMC article. Review.
Cited by
-
The Global Campaign turns 18: a brief review of its activities and achievements.J Headache Pain. 2022 Apr 21;23(1):49. doi: 10.1186/s10194-022-01420-0. J Headache Pain. 2022. PMID: 35448941 Free PMC article. Review.
-
The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research.J Headache Pain. 2018 Feb 2;19(1):12. doi: 10.1186/s10194-018-0837-3. J Headache Pain. 2018. PMID: 29396646 Free PMC article.
-
Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis.Front Pharmacol. 2021 Mar 25;12:649143. doi: 10.3389/fphar.2021.649143. eCollection 2021. Front Pharmacol. 2021. PMID: 33867991 Free PMC article.
-
Headache prevalence and demographic associations in the Delhi and National Capital Region of India: estimates from a cross-sectional nationwide population-based study.J Headache Pain. 2024 Jun 28;25(1):108. doi: 10.1186/s10194-024-01814-2. J Headache Pain. 2024. PMID: 38943062 Free PMC article.
-
Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.BMC Public Health. 2019 Sep 9;19(1):1242. doi: 10.1186/s12889-019-7461-2. BMC Public Health. 2019. PMID: 31500616 Free PMC article.
References
-
- World Health Organization . Headache disorders and public health. Education and management implications. Geneva: WHO; 2000.
-
- World Health Organization . The World Health Report 2001. Geneva: WHO; 2001.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical